Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited.

Stem Cells
Frank PajonkWilliam H McBride

Abstract

There is compelling evidence that many solid cancers are organized hierarchically and contain a small population of cancer stem cells (CSCs). It seems reasonable to suggest that a cancer cure can be achieved only if this population is eliminated. Unfortunately, there is growing evidence that CSCs are inherently resistant to radiation, and perhaps other cancer therapies. In general, success or failure of standard clinical radiation treatment is determined by the 4 R's of radiobiology: repair of DNA damage, redistribution of cells in the cell cycle, repopulation, and reoxygenation of hypoxic tumor areas. We relate recent findings on CSCs to these four phenomena and discuss possible consequences.

References

Dec 1, 1989·International Journal of Radiation Biology·G G SteelJ H Peacock
Feb 1, 1989·International Journal of Radiation Oncology, Biology, Physics·R P Hill, L Milas
Jan 1, 1988·Frontiers of Radiation Therapy and Oncology·H R WithersA Hliniak
Oct 15, 1995·International Journal of Radiation Oncology, Biology, Physics·H R WithersN Gupta
Feb 1, 1994·The Journal of Clinical Investigation·M H Barcellos-HoffJ A Weatherbee
Jan 1, 1994·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·K R Trott
Sep 1, 1996·Molecular Endocrinology·M H Barcellos-Hoff, T A Dix
May 1, 1997·International Journal of Radiation Oncology, Biology, Physics·D M BrizelM W Dewhirst
Oct 23, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E J EhrhartM H Barcellos-Hoff
Nov 2, 2001·Nature·T ReyaI L Weissman
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A FylesR P Hill
Feb 16, 2002·Acta Oncologica·J C Kummermehr
Oct 16, 2002·International Journal of Radiation Oncology, Biology, Physics·Friedo Zölzer, Christian Streffer
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Mar 26, 2003·International Journal of Radiation Oncology, Biology, Physics·Georg StübenPeter Vaupel
May 10, 2003·International Journal of Radiation Oncology, Biology, Physics·Rafal SuwinskiBoguslaw Maciejewski
May 17, 2003·Science·Monica Garcia-BarrosRichard Kolesnick
Dec 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Houman D HemmatiHarley I Kornblum
Jul 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Timothy M Pawlik, Khandan Keyomarsi
Oct 14, 2004·Oncogene·Frank PajonkMichael Henke
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Aug 16, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Marianne NordsmarkJens Overgaard
Oct 19, 2005·Cancer Research·Dong FangMeenhard Herlyn
Dec 3, 2005·Cancer Research·Anne T CollinsNorman J Maitland
Feb 4, 2006·Cell Death and Differentiation·A EramoR De Maria
Feb 21, 2006·Cancer Research·Richard P Hill
Aug 16, 2006·Development·Gerry Weinmaster, Raphael Kopan
Oct 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael HenkeFrank Pajonk
Nov 7, 2006·International Journal of Radiation Oncology, Biology, Physics·Ed R BlazekGuitta Maki

❮ Previous
Next ❯

Citations

Jul 16, 2011·Molecular Pharmaceutics·Marina CihovaCestmir Altaner
Jul 3, 2013·Nature Reviews. Drug Discovery·Everett J ModingDavid G Kirsch
Jan 22, 2011·Nature Reviews. Molecular Cell Biology·César Nombela-ArrietaLeslie E Silberstein
May 24, 2011·Tissue Engineering. Part a·Katherine A AhmannRobert T Tranquillo
Jul 22, 2011·Tissue Engineering. Part a·Akon HiguchiShih-Tien Hsu
Sep 6, 2013·Tissue Engineering. Part B, Reviews·Jeremy J Glynn, Monica T Hinds
Dec 29, 2010·PloS One·Chizuko TsurumiGabriele Niedermann
Jan 21, 2014·Mutation Research. Genetic Toxicology and Environmental Mutagenesis·Hamid KalantariHamid Gourabi
Nov 11, 2010·Future Oncology·Walter N HittelmanLuka Milas
Dec 20, 2012·Journal of Biomedicine & Biotechnology·Cord Naujokat, Roman Steinhart
Jun 5, 2012·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Lilian E van VlerkenRobert E Hollingsworth
Feb 24, 2016·Frontiers in Oncology·Kathryn D HeldAkihisa Takahashi
Dec 26, 2015·Bulletin du cancer·Benoîte MéryNicolas Magné
Oct 16, 2013·Critical Reviews in Oncology/hematology·Suna ZhouJun Liang
Mar 31, 2012·Cancer Letters·Coralie MoncharmontNicolas Magné
May 5, 2012·Journal of Theoretical Biology·H YoussefpourJ S Lowengrub
Mar 12, 2010·Seminars in Cancer Biology·Ulrike KochMichael Baumann
Jul 3, 2015·International Journal of Radiation Biology·Kyung-Hee SongJie-Young Song
Sep 19, 2015·Seminars in Radiation Oncology·Adam R Wolfe, Wendy A Woodward
Nov 9, 2012·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Paul J SmithRachel J Errington
Feb 24, 2016·Pharmacology & Therapeutics·Jihe Zhao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.